MAHE Inaugurates Manipal Hospice and Respite Centre, Revolutionizing Healthcare with Compassion
Largest in Karnataka and second largest Hospice and Respite Centre in India
100% philanthropic and free of cost for all age groups
It will offer two core services: Hospice and Respite Care
Manipal Academy of Higher Education (MAHE) marked a significant milestone in Indian healthcare industry with the successful inauguration of Manipal Hospice and Respite Centre (MHRC) at Havanje near Udupi on April 30, 2025. Hon'ble Justice Shri Syed Abdul Nazeer, His Excellency, the Governor of Andhra Pradesh inaugurated nation's one of its kind free of cost palliative care facility.
Manipal Hospice and Respite Centre inaugurated by Honorable Justice Shri Syed Abdul Nazeer, Governor of Andhra Pradesh
Dedicating the high impact social initiative of MAHE, hon'ble Governor Justice Shri Syed Abdul Nazeer said, 'MAHE's initiative to establish MHRC reflects a noble commitment to alleviate the suffering of those with advanced and terminal illnesses-treating compassionate care as a fundamental human right.'
Expressing deep concern over the alarming rise in cancer cases, the Governor highlighted the healthcare system's gaps. 'India reported 1.4 million new cancer cases in 2022, and yet less than 10% of patients in need receive palliative care. MHRC is a path-breaking step that shifts away from hospital-centric models and instead provides affordable, humane care-greatly reducing emotional and financial distress on families,' hon'ble Governor noted.
Applauding MHRC's values, the Governor added, 'This centre upholds the spirit of 'Manava Seve Madhava Seve'-service to mankind is service to God. By offering free, personalized, and dignified end-of-life care through philanthropic support, MHRC sets a benchmark in healthcare delivery. It is a visionary model that deserves to be replicated nationwide.'
Mrs. Vasanti R Pai, Trustee, MAHE Trust, Dr Ranjan Pai, President MAHE Trust, Registrar of Academy of General Education (AGE), and Chairman of Manipal Education and Medical Group (MEMG), Ashoka Pai, President of Dr TMA Pai Foundation, Dr HS Ballal, Pro-Chancellor of MAHE, Lt Gen (Dr) MD Venkatesh, Vice Chancellor, MAHE, Shri Kota Srinivas Poojary, Member of Parliament, Shri Yashpal Anand Suvarna, Member of Legislative Assembly, and Abhaya Chandra Jain, former Member of Legislative Assembly participated in this high profile event.
Senior officials of MAHE, Dr Narayana Sabhahit, Pro Vice Chancellor (Technology & Science), Dr Sharath K Rao, Pro Vice-Chancellor (Health Sciences), Dr Madhu Veeraraghavan, Pro Vice Chancellor (Management, Law, Humanities, and Social Sciences), Dr Dilip G Naik, Pro Vice Chancellor-Mangalore, Dr Raviraja NS, Chief Operating Officer – Operations, Dr P Giridhar Kini, Registrar and Dr. Vinod V. Thomas, Registrar (Evaluation),Dr Anand Venugopal, Chief Operating Officer-Teaching Hospitals, MAHE, Manipal, Dr. Avinash Shetty, Medical Superintendent, Kasturba Hospital Manipal (KMC Manipal), Dr Padmaraj Hegde, Dean, Kasturba Medical College Manipal, Dr Naveen Salins, Associate Dean and Professor & Head of the Department of Palliative Medicine and Supportive Care at KMC Manipal and Dr Seema Rao, Director, MHRC were present on the occasion.
A First in India: Free Palliative Care on a Lush Green Campus
The MHRC, located just outside Manipal on a lush 12-acre campus by the Swarna River, with 78% green zone prioritizing calm, and open environment that promotes well-being, is designed to offer compassionate care for patients facing serious and life-limiting illnesses. The facility will begin operations in June 2025 and will provide a full range of palliative and respite care services, completely free of charge. This 100-beded facility is the only hospice in India attached to both a medical college and tertiary care hospital, that caters to both cancer and non-cancer conditions. MHRC will provide innovative care models while training the next generation of palliative care specialists. The patient-centered approach will be further enhanced through innovative telehealth programs, ensuring accessible care for all who need it regardless of location.
MHRC combines both hospice (end-of-life) and respite (short-term relief) services under one roof, offering comprehensive pain and symptom management, wound and stoma care, nursing and rehabilitation services. A multidisciplinary team including doctors, nurses, counsellors, psychologists, physiotherapists, occupational therapists, social workers, and volunteers will provide holistic care that addresses physical, emotional, spiritual, and social needs. MHRC emphasizes dignity therapy, legacy work, rehabilitation, and family empowerment, along with medical care. It also integrates education and bereavement support, ensuring patients and their families are prepared and supported through every stage of serious illness and loss.
About Manipal Academy of Higher Education
The Manipal Academy of Higher Education (MAHE) is an Institution of Eminence Deemed-to-be University. MAHE offers over 400 specializations across the Health Sciences (HS), Management, Law, Humanities & Social Sciences (MLHS), and Technology & Science (T&S) streams through its constituent units at campuses in Manipal, Mangalore, Bengaluru, Jamshedpur, and Dubai. With a remarkable track record in academics, state-of-the-art infrastructure, and significant contributions to research, MAHE has earned recognition and acclaim both nationally and internationally. In October 2020, the Ministry of Education, Government of India, awarded MAHE the prestigious Institution of Eminence status. Currently ranked 4th in the National Institutional Ranking Framework (NIRF), MAHE is the preferred choice for students seeking a transformative learning experience and an enriching campus life, as well as for national & multi-national corporates looking for top talent.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
2 hours ago
- News18
Eating For Immunity: Traditional Indian Foods That Heal From Within
Small daily choices, grounded in tradition and supported by science and supplemented when needed under medical advice are the way to nourish it from within In an era of pills and powders, our traditional Indian diets remind us that true immunity is built not bought. 'As both a physician and wellness coach, I find increasing resonance between what modern science proves and what our grandmothers always knew," says Dr. Aparna Santhanam, Dermatologist & Holistic Wellness Coach. Take haldi doodh, for example. Curcumin, the active compound in turmeric, has been shown to modulate immune responses and reduce systemic inflammation (Journal of Clinical Immunology, 2018). When paired with black pepper which enhances its absorption by up to 2000% (Planta Medica, 1998) it becomes a potent daily shield. Kadha, that humble brew of tulsi, ginger, cinnamon, and black pepper, is not just folklore. Tulsi has demonstrated immunomodulatory effects, and ginger is known for its antiviral and anti-inflammatory properties (Frontiers in Pharmacology, 2020). A warm cup daily during seasonal transitions can truly help you stay well. 'Gut health is central to immunity. Studies now affirm that fermented foods like curd, idli, and kanji improve gut microbiota diversity by directly influencing immune function (Cell, 2021). A spoon of homemade pickle or fermented rice adds even more probiotic richness," shares Dr Santhanam. But beyond what we eat, how we eat matters too. Warm, fresh meals eaten mindfully—with seasonal rhythm, cultural context, and locally sourced ingredients—play a critical role in building and maintaining immunity. At the end of the day, it's important to understand that immunity isn't built in a day or by simply popping a pill. Small daily choices, grounded in tradition and supported by science and supplemented when needed under medical advice are the way to nourish it from within, one wholesome meal and one steady habit at a time. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
3 hours ago
- Time of India
Bengaluru's deep-tech startup proposes 'quantum' leap in cancer care
A Bengaluru-based bootstrapped deep-tech startup is leveraging quantum technology to detect cellular damage even before the symptoms appear in just hours, possibly changing the game for cancer care One among the 20-odd exhibitors at the recently concluded Quantum India Bengaluru Summit, Quantum Biosciences Private Limited's "predictive tech" uses quantum biosensor to detect unique 'magnetic fingerprints' of oxidative stress in cells, allowing detection of tissue his wife was diagnosed with cancer and had to undergo radiation therapy, Ravi Puvvala, Managing Director of Quantum Biosciences, who was earlier developing sensors for automotive industry, said he started exploring the possibility of using sensors to predict radiation-induced cardiotoxicity before irreversible damage."Radiation therapy is essential for treating cancer. But it kills not only the cancerous cells, also the good ones. This leads to long-term complications such as fatigue, cognitive decline, organ dysfunction and secondary cancers. It also potentially induces a heart disease or fibrosis. I watched my wife suffer because of some of these side effects," Puvvala told diagnostic tools, such as MRI, PET scans and blood biomarkers only detect harm after significant damage has already occurred, said Puvvala."So, I wanted to use my experience in building sensors, and, you know, explore technology, understand how to optimise this particular problem," added has been building technologies for the last 15 years, Puvvala took a quantum leap when he partnered with the Netherlands-based QT Sense, led by another Indian, Deepak Veeragowda. QT Sense was formed to take forward the 15 years of academic research done in this area at the University of Sense's Quantum Nuova is a platform technology built for detecting quantum-level phenomena like subcellular free radicals and magnetic biomarkers."For the last two years, we have been researching various potential technologies for early stage diagnostics. We looked at classical sensors and quantum sensors , and we started quantum biosensors to leverage the potential of quantum sensors," said said while quantum biosensors can tell us that there exists a certain amount of stress at the subcellular level, the next step would be to understand how to read them."Further research is needed on how to map the cellular stress to a potential biomarker, only then we can say, okay, we made the prognosis," added the first edition of the Quantum India Bengaluru Summit, Puvvala reached out to researchers and other key stakeholders - including the government of Karnataka, academic institutions, acute care clinicians, pharmaceutical companies and hospitals -- exploring this idea."To build this technology, we need a whole village. We need the engineering team, we need the medical team, and we need, you know, people like us, who can put all this together," said to him, they still need to do a lot of validation with respect to the sub cellular detection."For the first time we're able to actually go inside the cell and measure all kinds of things. But now we need to be able to make sense of what these measurements mean through clinical tests. So we need to conduct tests, and we need to be able to come up with a diagnostic mechanism," said this end, Puvvala said they would be spending the next two years working with various hospitals, both in India and abroad."We want to partner with cancer centres particularly, so we could get the necessary data," said Biosciences is at present incubating its foundational research capabilities at Center for Cellular and Molecular Platforms (C-CAMP), an initiative of Department of Biotechnology, Ministry of Science and Technology, Government of India and at Center for Nano Science and Engineering (CeNSE) in Indian Institute of Science (IISc), Bengaluru, he added."We are also talking to other ecosystem leaders and state-level innovation programs to co-develop a shared infrastructure that bridges deep-science research with clinical applications," said they go past the "very base-level mechanism", the technology, said Puvvala, would benefit not only oncology, but also nephrology, cardiovascular and neurodegenerative could even help India's most basic struggle in providing health care, he added."One of the things I've heard at the conference is that most hospitals are overcrowded because the primary health care and the critical health care have been combined into one. The quantum biosensor could, you know, reduce the primary health care overload, by precisely identifying those cases that need critical care at a considerably lesser time," said Puvvala.
Economic Times
3 hours ago
- Economic Times
Bengaluru's deep-tech startup proposes 'quantum' leap in cancer care
Agencies A Bengaluru-based bootstrapped deep-tech startup is leveraging quantum technology to detect cellular damage even before the symptoms appear in just hours, possibly changing the game for cancer care. One among the 20-odd exhibitors at the recently concluded Quantum India Bengaluru Summit, Quantum Biosciences Private Limited's "predictive tech" uses quantum biosensor to detect unique 'magnetic fingerprints' of oxidative stress in cells, allowing detection of tissue injury. When his wife was diagnosed with cancer and had to undergo radiation therapy, Ravi Puvvala, Managing Director of Quantum Biosciences, who was earlier developing sensors for automotive industry, said he started exploring the possibility of using sensors to predict radiation-induced cardiotoxicity before irreversible damage. "Radiation therapy is essential for treating cancer. But it kills not only the cancerous cells, also the good ones. This leads to long-term complications such as fatigue, cognitive decline, organ dysfunction and secondary cancers. It also potentially induces a heart disease or fibrosis. I watched my wife suffer because of some of these side effects," Puvvala told PTI. Existing diagnostic tools, such as MRI, PET scans and blood biomarkers only detect harm after significant damage has already occurred, said Puvvala. "So, I wanted to use my experience in building sensors, and, you know, explore technology, understand how to optimise this particular problem," added Puvvala. He has been building technologies for the last 15 years, Puvvala said. Things took a quantum leap when he partnered with the Netherlands-based QT Sense, led by another Indian, Deepak Veeragowda. QT Sense was formed to take forward the 15 years of academic research done in this area at the University of Groningen. QT Sense's Quantum Nuova is a platform technology built for detecting quantum-level phenomena like subcellular free radicals and magnetic biomarkers. "For the last two years, we have been researching various potential technologies for early stage diagnostics. We looked at classical sensors and quantum sensors, and we started quantum biosensors to leverage the potential of quantum sensors," said Puvvala. Puvvala said while quantum biosensors can tell us that there exists a certain amount of stress at the subcellular level, the next step would be to understand how to read them. "Further research is needed on how to map the cellular stress to a potential biomarker, only then we can say, okay, we made the prognosis," added Puvvala. At the first edition of the Quantum India Bengaluru Summit, Puvvala reached out to researchers and other key stakeholders - including the government of Karnataka, academic institutions, acute care clinicians, pharmaceutical companies and hospitals -- exploring this idea. "To build this technology, we need a whole village. We need the engineering team, we need the medical team, and we need, you know, people like us, who can put all this together," said Puvvala. According to him, they still need to do a lot of validation with respect to the sub cellular detection. "For the first time we're able to actually go inside the cell and measure all kinds of things. But now we need to be able to make sense of what these measurements mean through clinical tests. So we need to conduct tests, and we need to be able to come up with a diagnostic mechanism," said Puvvala. To this end, Puvvala said they would be spending the next two years working with various hospitals, both in India and abroad. "We want to partner with cancer centres particularly, so we could get the necessary data," said Puvvala. Quantum Biosciences is at present incubating its foundational research capabilities at Center for Cellular and Molecular Platforms (C-CAMP), an initiative of Department of Biotechnology, Ministry of Science and Technology, Government of India and at Center for Nano Science and Engineering (CeNSE) in Indian Institute of Science (IISc), Bengaluru, he added. "We are also talking to other ecosystem leaders and state-level innovation programs to co-develop a shared infrastructure that bridges deep-science research with clinical applications," said Puvvala. When they go past the "very base-level mechanism", the technology, said Puvvala, would benefit not only oncology, but also nephrology, cardiovascular and neurodegenerative diseases. It could even help India's most basic struggle in providing health care, he added. "One of the things I've heard at the conference is that most hospitals are overcrowded because the primary health care and the critical health care have been combined into one. The quantum biosensor could, you know, reduce the primary health care overload, by precisely identifying those cases that need critical care at a considerably lesser time," said Puvvala. Elevate your knowledge and leadership skills at a cost cheaper than your daily tea. Zomato delivered, but did the other listed unicorns? US tariff hike to hit Indian exports, may push RBI towards rate cuts Will TCS layoffs open the floodgates of mass firing at Indian IT firms? Indian IT firms never reveal the truth hiding behind 'strong' deal wins Is Bajaj Finance facing its HDFC Bank moment? Tata Motors' INR38k crore Iveco buy: Factors that can make investors nervous Stock Radar: Strides Pharma stock hits fresh 52-week high in July; will the rally continue in August? F&O Radar| Deploy Short Strangle in Nifty to gain from Theta decay For investors who can think beyond Trump: 5 large-cap stocks with an upside potential of up to 36%
